Clinicians continually face challenges with determining underlying causes of thrombosis. Deficiencies of Antithrombin and Protein C require patients to receive proper treatment, and diagnostic methods often may be confounded by the prevalence of onboard anticoagulation.
We invite you to join us for a webinar on Wednesday, December 14 with Dr. John Mitsios, PhD, as he discusses the best practices for understanding and utilizing the new International Society of Thrombosis and Hemostasis (ISTH) guidelines on how and when to test for optimal patient management.
During this presentation he will:
- Review the basics of hemostasis
- Discuss the prevalent assays in thrombophilia testing
- Describe the new ISTH guidelines for Antithrombin and Protein C testing
Speaker:
Dr. Mitsios graduated from the University of Ioannina, Greece with a PhD in Chemistry. Upon completion of his doctoral thesis, he then went on to complete a post-doctoral fellowship at the University of California, San Diego. Dr. Mitsios then transitioned to the world of Clinical Chemistry and completed a fellowship at Washington University in St. Louis, MO. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Dr. Mitsios joined Siemens-Healthineers as a clinical consultant as part of the Scientific and Clinical Affairs team. In addition, Dr. Mitsios has co-authored 20 peer-reviewed articles and 3 book chapters.
